The China artificial hip and knee joints market was valued at USD 597.0 million in 2023 and is projected to reach USD 1.01 billion by 2030, growing at a CAGR of 7.8% from 2024 to 2030. Market growth is primarily driven by the rising incidence of hip and knee injuries, obesity, and osteoarthritis, along with the increasing preference for minimally invasive surgical procedures. For instance, according to an article published by John Wiley & Sons, Inc. in September 2023, knee osteoarthritis remains a major public health concern in China, with tenderness and joint pain affecting between 36.8% and 60.7% of the population. These factors collectively highlight the growing demand for advanced joint replacement devices across the country.

The expanding geriatric population in China is another significant factor contributing to market growth. Older adults are highly prone to bone-related disorders, such as arthritis, osteoporosis, and hip fractures, which often require surgical intervention. According to government statistics released in January 2024, approximately 297 million people in China were aged 60 and above in 2023, making it a “super-aged society” as per World Bank standards. This number is projected to exceed 500 million by 2050, further driving the demand for artificial hip and knee joints in the coming years.

The market is witnessing continuous innovation driven by advancements in surgical techniques, biomechanics, and materials science. The introduction of custom-designed implants and minimally invasive surgical procedures has led to improved patient outcomes, shorter recovery times, and reduced postoperative complications. Moreover, the industry has seen a moderate level of merger and acquisition (M&A) activity, as companies aim to strengthen their product portfolios, expand their technological capabilities, and enhance operational efficiency. These collaborations are helping manufacturers gain access to complementary expertise, distribution networks, and R&D resources, supporting market expansion.

Key Market Trends & Insights:

  • By Site: The knee joints segment dominated the China artificial hip and knee joints market in 2023, accounting for the largest revenue share of 61.2%, driven by the growing prevalence of knee-related disorders, particularly osteoarthritis, which has increased the demand for total knee arthroplasty (TKA) procedures. The hip joints segment is expected to register the fastest CAGR over the forecast period, owing to a surge in hip fractures among the elderly population and increasing adoption of advanced hip implant technologies.
  • By End Use: The hospitals and surgery centers segment led the market in 2023, with a 69.7% revenue share, attributed to the large number of orthopedic surgeries performed in these settings and the presence of advanced surgical infrastructure. The orthopedic clinics segment is projected to experience significant growth during the forecast period due to their specialized expertise in musculoskeletal care and growing patient preference for outpatient procedures.

Order a free sample PDF of the China Artificial Hip & Knee Joints Market Intelligence Study, published by Grand View Research.

Key Players

  • Zimmer Biomet
  • Stryker
  • Smith+Nephew
  • AK Medical
  • Waston Medical Corporation
  • Extremity Medical LLC
  • CONMED Corporation.
  • Enovis Corporation
  • Johnson & Johnson (DePuy Synthes)
  • Aesculap, Inc. (B. Braun)


Recent Developments

  • March 2024: Stryker Corporation acquired SERF SAS, a joint replacement company known for its innovative hip implant technologies such as the Dual Mobility Cup. This acquisition aims to enhance Stryker’s orthopedic product portfolio and strengthen its global presence in joint replacement solutions.
  • July 2021: Zimmer Biomet entered a partnership with OSSIS to become the exclusive distributor of 3D-printed, patient-specific titanium hip replacement joints across the Asia-Pacific region. This collaboration is designed to improve surgical outcomes in complex orthopedic cases, including revision surgeries and bone tumor treatments.
  • June 2021: MicroPort Orthopedics partnered with PatientIQ to improve patient education and engagement in orthopedic care through digital platforms. This initiative provides patients with valuable tools and resources to better understand their conditions and treatment options, enhancing satisfaction and post-surgical recovery outcomes.


Overall, the China artificial hip and knee joints market is poised for robust growth, supported by an aging population, technological advancements, and increasing healthcare accessibility. Strategic collaborations, innovation in implant design, and a shift toward minimally invasive procedures will continue to shape the future of the orthopedic industry in China.


Explore Horizon Databook – The world's most expansive market intelligence platform developed by Grand View Research.

Conclusion:

In conclusion, the China artificial hip and knee joints market is set to witness substantial growth driven by the rising prevalence of osteoarthritis, hip fractures, and other joint-related disorders, especially among the aging population. Continuous advancements in implant technology, materials science, and minimally invasive surgical techniques are improving patient outcomes and accelerating adoption. Strategic collaborations, mergers, and technological innovations by key market players are further strengthening the industry landscape. Overall, the market is expected to maintain strong momentum as China’s healthcare system continues to prioritize orthopedic advancements and improved quality of life for its aging population.